725
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Can be marine bioactive peptides (MBAs) lead the future of foodomics for human health?

, , , , , , , , ORCID Icon & show all

References

  • Achour, A., A. Lachgar, A. Astgen, V. Chams, B. Bizzini, H. Tapiero, and D. Zagury. 1997. Potentialization of IL-2 effects on immune cells by oyster extract (JCOE) in normal and HIV-infected individuals. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 51 (10):427–9. doi: 10.1016/S0753-3322(97)82320-7.
  • Afifi, A. H., A. H. El-Desoky, H. Kato, R. E. Mangindaan, N. J. de Voogd, N. M. Ammar, M. S. Hifnawy, and S. Tsukamoto. 2016. Carteritins A and B, cyclic heptapeptides from the marine sponge Stylissa carteri. Tetrahedron Letters 57 (11):1285–8. doi: 10.1016/j.tetlet.2016.02.031.
  • Ahhmed, A. M., and M. Muguruma. 2010. A review of meat protein hydrolysates and hypertension. Meat Science 86 (1):110–8. doi: 10.1016/j.meatsci.2010.04.032.
  • Amagata, T., B. I. Morinaka, A. Amagata, K. Tenney, F. A. Valeriote, E. Lobkovsky, J. Clardy, and P. Crews. 2006. A chemical study of cyclic depsipeptides produced by a sponge-derived fungus. Journal of Natural Products 69 (11):1560–5. doi: 10.1021/np060178k.
  • Anand, T. P., C. Chellaram, G. Kuberan, and H. Archana. 2012. Bioactive peptides from marine sources-a review. Indian Journal of Innovations and Developments 1:61–4.
  • Andavan, G. S. B., and R. Lemmens-Gruber. 2010. Cyclodepsipeptides from marine sponges: Natural agents for drug research. Marine Drugs 8 (3):810–34. doi: 10.3390/md8030810.
  • Andjelic, C. D., V. Planelles, and L. R. Barrows. 2008. Characterizing the anti-HIV activity of papuamide A. Marine Drugs 6 (4):528–49. doi: 10.3390/md20080027.
  • Aneiros, A., and A. Garateix. 2004. Bioactive peptides from marine sources: Pharmacological properties and isolation procedures. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 803 (1):41–53. doi: 10.1016/j.jchromb.2003.11.005.
  • Arumugam, V., M. Venkatesan, S. Ramachandran, and U. Sundaresan. 2018. Bioactive peptides from marine ascidians and future drug development–A Review. International Journal of Peptide Research and Therapeutics 24 (1):13–8. doi: 10.1007/s10989-017-9662-9.
  • Balunas, M. J., R. G. Linington, K. Tidgewell, A. M. Fenner, L.-D. Urena, G. D. Togna, D. E. Kyle, and W. H. Gerwick. 2010. Dragonamide E, a modified linear lipopeptide from Lyngbya majuscula with antileishmanial activity. Journal of Natural Products 73 (1):60–6. doi: 10.1021/np900622m.
  • Battison, A. L., R. Summerfield, and A. Patrzykat. 2008. Isolation and characterisation of two antimicrobial peptides from haemocytes of the American lobster Homarus americanus. Fish & Shellfish Immunology 25 (1–2):181–7. doi: 10.1016/j.fsi.2008.04.005.
  • Baudin, E., J. P. Droz, L. Paz-Ares, A. T. van Oosterom, M. Cullell-Young, and M. Schlumberger. 2010. Phase II study of plitidepsin 3-hour infusion every 2 weeks in patients with unresectable advanced medullary thyroid carcinoma. American Journal of Clinical Oncology 33 (1):83–8. doi: 10.1097/COC.0b013e31819fdf5e.
  • Belofsky, G. N., P. R. Jensen, and W. Fenical. 1999. Sansalvamide: A new cytotoxic cyclic depsipeptide produced by a marine fungus of the genus Fusarium. Tetrahedron Letters 40 (15):2913–6. doi: 10.1016/S0040-4039(99)00393-7.
  • Bendell, J., M. Saleh, A. A. N. Rose, P. M. Siegel, L. Hart, S. Sirpal, S. Jones, J. Green, E. Crowley, R. Simantov, et al. 2014. Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 32 (32):3619–25. doi: 10.1200/JCO.2013.52.5683.
  • Bertram, A., and G. Pattenden. 2007. Marine metabolites: Metal binding and metal complexes of azole-based cyclic peptides of marine origin. Natural Product Reports 24 (1):18–30. doi: 10.1039/b612600f.
  • Bhaskar, N., T. Benila, C. Radha, and R. G. Lalitha. 2008. Optimization of enzymatic hydrolysis of visceral waste proteins of Catla (Catla catla) for preparing protein hydrolysate using a commercial protease. Bioresource Technology 99 (2):335–43. doi: 10.1016/j.biortech.2006.12.015.
  • Blunt, J. W., B. R. Copp, R. A. Keyzers, M. H. Munro, and M. R. Prinsep. 2013. Marine natural products. Natural Product Reports 30 (2):237–323. doi: 10.1039/c2np20112g.
  • Boot, C. M., K. Tenney, F. A. Valeriote, and P. Crews. 2006. Highly N-methylated linear peptides produced by an atypical sponge-derived Acremonium sp. Journal of Natural Products 69 (1):83–92. doi: 10.1021/np0503653.
  • Bougatef, A., N. Nedjar-Arroume, R. Ravallec-Plé, Y. Leroy, D. Guillochon, A. Barkia, and M. Nasri. 2008. Angiotensin I-converting enzyme (ACE) inhibitory activities of sardinelle (Sardinella aurita) by-products protein hydrolysates obtained by treatment with microbial and visceral fish serine proteases. Food Chemistry 111 (2):350–6. doi: 10.1016/j.foodchem.2008.03.074.
  • Braekman, J. C., D. Daloze, B. Moussiaux, and R. Riccio. 1987. Jaspamide from the marine sponge Jaspis johnstoni. Journal of Natural Products 50 (5):994–5. doi: 10.1021/np50053a048.
  • Broggini, M., S. V. Marchini, E. Galliera, P. Borsotti, G. Taraboletti, E. Erba, M. Sironi, J. Jimeno, G. T. Faircloth, R. Giavazzi, et al. 2003. Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4. Leukemia 17 (1):52–9. doi: 10.1038/sj.leu.2402788.
  • Brust, A., E. Palant, D. E. Croker, B. Colless, R. Drinkwater, B. Patterson, C. I. Schroeder, D. Wilson, C. K. Nielsen, M. T. Smith, et al. 2009. chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain. Journal of Medicinal Chemistry 52 (22):6991–7002. doi: 10.1021/jm9003413.
  • Byun, H.-G., and S.-K. Kim. 2001. Purification and characterization of angiotensin I converting enzyme (ACE) inhibitory peptides from Alaska pollack (Theragra chalcogramma) skin. Process Biochemistry 36 (12):1155–62. doi: 10.1016/S0032-9592(00)00297-1.
  • Byun, H.-G., J. K. Lee, H. G. Park, J.-K. Jeon, and S.-K. Kim. 2009. Antioxidant peptides isolated from the marine rotifer, Brachionus rotundiformis. Process Biochemistry 44 (8):842–6. doi: 10.1016/j.procbio.2009.04.003.
  • Carroll, A. R., B. F. Bowden, J. C. Coll, D. C. Hockless, B. W. Skelton, and A. H. White. 1994. Studies of Australian ascidians. IV. Mollamide, a cytotoxic cyclic heptapeptide from the compound ascidian Didemnum molle. Australian Journal of Chemistry 47 (1):61–9. doi: 10.1071/CH9940061.
  • Carroll, A. R., Y. Feng, B. F. Bowden, and J. C. Coll. 1996. Studies of Australian ascidians. 5. Virenamides A − C, new cytotoxic linear peptides from the colonial didemnid ascidian Diplosoma virens. The Journal of Organic Chemistry 61 (12):4059–61. doi: 10.1021/jo951379o.
  • Centenaro, G. S., M. S. Centenaro, and C. P. Hernandez. 2011. Antioxidant activity of protein hydrolysates of fish and chicken bones. Journal of Food Science Techology 3: 280–288.
  • Chan, W. R., W. F. Tinto, P. S. Manchand, and L. J. Todaro. 1987. Stereostructures of geodiamolides A and B, novel cyclodepsipeptides from the marine sponge Geodia sp. The Journal of Organic Chemistry 52 (14):3091–3. doi: 10.1021/jo00390a023.
  • Charoensiddhi, S., M. A. Conlon, C. M. M. Franco, and W. Zhang. 2017. The development of seaweed-derived bioactive compounds for use as prebiotics and nutraceuticals using enzyme technologies. Trends in Food Science & Technology 70:20–33. doi: 10.1016/j.tifs.2017.10.002.
  • Chen, Z., Y. Song, Y. Chen, H. Huang, W. Zhang, and J. Ju. 2012. Cyclic heptapeptides, cordyheptapeptides C-E, from the marine-derived fungus Acremonium persicinum SCSIO 115 and their cytotoxic activities. Journal of Natural Products 75 (6):1215–9. doi: 10.1021/np300152d.
  • Cheung, R. C. F., T. B. Ng, and J. H. Wong. 2015. Marine peptides: Bioactivities and applications. Marine Drugs 13 (7):4006–43. doi: 10.3390/md13074006.
  • Ciavatta, M. L., F. Lefranc, M. Carbone, E. Mollo, M. Gavagnin, T. Betancourt, R. Dasari, A. Kornienko, and R. Kiss. 2017. Marine mollusk-derived agents with antiproliferative activity as promising anticancer agents to overcome chemotherapy resistance. Medicinal Research Reviews 37 (4):702–801. doi: 10.1002/med.21423.
  • Cioca, D., and K. Kitano. 2002. Induction of apoptosis and CD10/neutral endopeptidase expression by jaspamide in HL-60 line cells. Cellular and Molecular Life Sciences: CMLS 59 (8):1377–87. doi: 10.1007/s00018-002-8515-6.
  • Coleman, J. E., R. Van Soest, and R. J. Andersen. 1999. New geodiamolides from the sponge Cymbastela sp. collected in Papua New Guinea. Journal of Natural Products 62 (8):1137–41. doi: 10.1021/np990155o.
  • Costa, M., J. Costa-Rodrigues, M. H. Fernandes, P. Barros, V. Vasconcelos, and R. Martins. 2012. Marine cyanobacteria compounds with anticancer properties: A review on the implication of apoptosis. Marine Drugs 10 (10):2181–207. doi: 10.3390/md10102181.
  • Cude, W. N., J. Mooney, A. A. Tavanaei, M. K. Hadden, A. M. Frank, C. A. Gulvik, A. L. May, and A. Buchan. 2012. Production of the antimicrobial secondary metabolite indigoidine contributes to competitive surface colonization by the marine roseobacter Phaeobacter sp. strain Y4I. Applied and Environmental Microbiology 78 (14):4771–80. doi: 10.1128/AEM.00297-12.
  • de Silva, E. D., R. J. Andersen, and T. M. Allen. 1990. Geodiamolides C to F, new cytotoxic cyclodepsipeptides from the marine sponge Pseudaxinyssa sp. Tetrahedron Letters 31 (4):489–92. doi: 10.1016/0040-4039(90)87015-R.
  • DeFelice, S. L. 1995. The nutraceutical revolution: Its impact on food industry R&D. Trends in Food Science & Technology 6 (2):59–61. doi: 10.1016/S0924-2244(00)88944-X.
  • Dey, S. S., and K. C. Dora. 2014. Antioxidative activity of protein hydrolysate produced by alcalase hydrolysis from shrimp waste (Penaeus monodon and Penaeus indicus). Journal of Food Science and Technology 51 (3):449–57. doi: 10.1007/s13197-011-0512-z.
  • Ding, L.-J., W. Yuan, X.-J. Liao, B.-N. Han, S.-P. Wang, Z.-Y. Li, S.-H. Xu, W. Zhang, and H.-W. Lin. 2016. Oryzamides A-E, cyclodepsipeptides from the sponge-derived fungus Nigrospora oryzae PF18. Journal of Natural Products 79 (8):2045–52. doi: 10.1021/acs.jnatprod.6b00349.
  • Donia, M. S., B. Wang, D. C. Dunbar, P. V. Desai, A. Patny, M. Avery, and M. T. Hamann. 2008. Mollamides B and C, cyclic hexapeptides from the Indonesian tunicate Didemnum molle. Journal of Natural Products 71 (6):941–5. doi: 10.1021/np700718p.
  • Dorr, F. A., J. G. Kuhn, J. Phillips, and D. D. von Hoff. 1988. Phase I clinical and pharmacokinetic investigation of didemnin B, a cyclic depsipeptide. European Journal of Cancer & Clinical Oncology 24 (11):1699–706. doi: 10.1016/0277-5379(88)90070-3.
  • Douglas, S. E., J. W. Gallant, R. S. Liebscher, A. Dacanay, and S. C. Tsoi. 2003. Identification and expression analysis of hepcidin-like antimicrobial peptides in bony fish. Developmental and Comparative Immunology 27 (6–7):589–601. doi: 10.1016/S0145-305X(03)00036-3.
  • Doyen, A., L. Beaulieu, L. Saucier, Y. Pouliot, and L. Bazinet. 2011. Impact of ultrafiltration membrane material on peptide separation from a snow crab byproduct hydrolysate by electrodialysis with ultrafiltration membranes. Journal of Agricultural and Food Chemistry 59 (5):1784–92. doi: 10.1021/jf103739m.
  • Dumez, H., E. Gallardo, S. Culine, J. C. Galceran, P. Schöffski, J. P. Droz, S. Extremera, S. Szyldergemajn, and A. Fléchon. 2009. Phase II study of biweekly plitidepsin as second-line therapy for advanced or metastatic transitional cell carcinoma of the urothelium. Marine Drugs 7 (3):451–63. doi: 10.3390/md7030451.
  • Edler, M. C., A. M. Fernandez, P. Lassota, C. M. Ireland, and L. R. Barrows. 2002. Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin 10. Biochemical Pharmacology 63 (4):707–15. doi: 10.1016/S0006-2952(01)00898-X.
  • El Maddah, F., S. Kehraus, M. Nazir, C. Almeida, and G. M. König. 2016. Insights into the biosynthetic origin of 3-(3-Furyl)alanine in Stachylidium sp. 293 K04 Tetrapeptides. Journal of Natural Products 79 (11):2838–45. doi: 10.1021/acs.jnatprod.6b00601.
  • Erdmann, K., B. W. Cheung, and H. Schröder. 2008. The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. The Journal of Nutritional Biochemistry 19 (10):643–54. doi: 10.1016/j.jnutbio.2007.11.010.
  • Fahmi, A., S. Morimura, H.-C. Guo, T. Shigematsu, K. Kida, and Y. Uemura. 2004. Production of angiotensin I converting enzyme inhibitory peptides from sea bream scales. Process Biochemistry 39 (10):1195–200. doi: 10.1016/S0032-9592(03)00223-1.
  • Faivre, S., S. Chièze, C. Delbaldo, N. Ady-Vago, C. Guzman, L. Lopez-Lazaro, S. Lozahic, J. Jimeno, F. Pico, and J. P. Armand. 2005. Phase I and pharmacokinetic study of aplidine, a new marine cyclodepsipeptide in patients with advanced malignancies. Journal of Clinical Oncology. 23: 7871–7880.
  • Ford, P. W., K. R. Gustafson, T. C. McKee, N. Shigematsu, L. K. Maurizi, L. K. Pannell, D. E. Williams, E. Dilip de Silva, P. Lassota, T. M. Allen, et al. 1999. Papuamides A − D, HIV-inhibitory and cytotoxic depsipeptides from the Sponges Theonella m irabilis and Theonella s winhoei collected in Papua New Guinea. Journal of the American Chemical Society 121 (25):5899–909. doi: 10.1021/ja990582o.
  • Foster, M. P., G. P. Concepcion, G. B. Caraan, and C. M. Ireland. 1992. Bistratamides C and D. Two new oxazole-containing cyclic hexapeptides isolated from a Philippine Lissoclinum bistratum ascidian. The Journal of Organic Chemistry 57 (24):6671–5. doi: 10.1021/jo00050a063.
  • Fu, X., J. Su, and L. Zeng. 2000. Prepatellamide A, a new cyclic peptide from the ascidianLissoclinum patella. Science in China Series B: Chemistry 43 (6):643–8. doi: 10.1007/BF02969512.
  • Fukuda, Y., T. Sugahara, M. Ueno, Y. Fukuta, Y. Ochi, K. Akiyama, T. Miyazaki, S. Masuda, A. Kawakubo, and K. Kato. 2006. The anti-tumor effect of Euchema serra agglutinin on colon cancer cells in vitro and in vivo. Anti-Cancer Drugs 17 (8):943–7. doi: 10.1097/01.cad.0000224458.13651.b4.
  • Gamble, W. R., N. A. Durso, R. W. Fuller, C. K. Westergaard, T. R. Johnson, D. L. Sackett, E. Hamel, J. H. Cardellina, and M. R. Boyd. 1999. Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp. and Siphonochalina spp. sponges. Bioorganic & Medicinal Chemistry 7 (8):1611–5. doi: 10.1016/S0968-0896(99)00089-9.
  • Gao, J., and M. T. Hamann. 2011. Chemistry and biology of kahalalides. Chemical Reviews 111 (5):3208–35. doi: 10.1021/cr100187n.
  • Gao, X., Y. Liu, S. Kwong, Z. Xu, and T. Ye. 2010. Total synthesis and stereochemical reassignment of bisebromoamide. Organic Letters 12 (13):3018–21. doi: 10.1021/ol101021v.
  • García-Fernández, L. F., A. Losada, V. Alcaide, A. M. Alvarez, A. Cuadrado, L. González, K. Nakayama, K. I. Nakayama, J. M. Fernández-Sousa, A. Muñoz, et al. 2002. Aplidin induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C delta. Oncogene 21 (49):7533–44. doi: 10.1038/sj.onc.1205972.
  • Garg, H. 1994. Bioactive substances in marine algae. In Nutrients and bioactive substances in aquatic organisms, eds. K. Devadasan, M. Mukundan, P. Antony, P. Viswanathan Nair, P. Perigreen, and J. Joseph, 16. Cochin, India: Society of Fisheries Technologists.
  • Ghanbari, R., and A. Ebrahimpour. 2018. Separation and identification of bromelain-generated antibacterial peptides from Actinopyga lecanora. Food Science and Biotechnology 27 (2):591–8. doi: 10.1007/s10068-017-0267-z.
  • Giri, A., and T. Ohshima. 2012. Bioactive marine peptides: Nutraceutical value and novel approaches. Advances in Food and Nutrition Research 65:73–105. doi: 10.1016/B978-0-12-416003-3.00005-6.
  • Gutiérrez, M., T. L. Suyama, N. Engene, J. S. Wingerd, T. Matainaho, and W. H. Gerwick. 2008. Apratoxin D, a potent cytotoxic cyclodepsipeptide from Papua New Guinea collections of the marine cyanobacteria Lyngbya majuscula and Lyngbya sordida. Journal of Natural Products 71 (6):1099–103. doi: 10.1021/np800121a.
  • Hamada, Y., and T. Shioiri. 2005. Recent progress of the synthetic studies of biologically active marine cyclic peptides and depsipeptides. Chemical Reviews 105 (12):4441–82. doi: 10.1021/cr0406312.
  • Hamann, M. T., C. S. Otto, P. J. Scheuer, and D. C. Dunbar. 1996. Kahalalides: Bioactive peptides from a marine mollusk Elysia rufescens and its algal diet Bryopsis sp.(1). The Journal of Organic Chemistry 61 (19):6594–600. doi: 10.1021/jo960877+.
  • Hambley, T. W., C. J. Hawkins, M. F. Lavin, A. van den Brenk, and D. J. Watters. 1992. Cycloxazoline: A cytotoxic cyclic hexapeptide from the ascidian lissoclinum bistratum. Tetrahedron 48 (2):341–8. doi: 10.1016/S0040-4020(01)88146-1.
  • Han, B., H. Gross, K. L. McPhail, D. Goeger, C. S. Maier, and W. H. Gerwick. 2011. Wewakamide A and guineamide G, cyclic depsipeptides from the marine cyanobacteria Lyngbya semiplena and Lyngbya majuscula. Journal of Microbiology and Biotechnology 21 (9):930–6. doi: 10.4014/jmb.1105.05011.
  • Harada, K., T. Maeda, Y. Hasegawa, T. Tokunaga, Y. Tamura, and T. Koizumi. 2010. Antioxidant activity of fish sauces including puffer (Lagocephalus wheeleri) fish sauce measured by the oxygen radical absorbance capacity method. Molecular Medicine Reports 3 (4):663–8. doi: 10.3892/mmr_00000313.
  • Harnedy, P. A., and R. J. FitzGerald. 2011. Bioactive proteins, peptides, and amino acids from macroalgae(1). Journal of Phycology 47 (2):218–32. doi: 10.1111/j.1529-8817.2011.00969.x.
  • Hori, K., S. Ikegami, K. Miyazawa, and K. Ito. 1988. Mitogenic and antineoplastic isoagglutinins from the red alga Solieria robusta. Phytochemistry 27 (7):2063–7. doi: 10.1016/0031-9422(88)80097-9.
  • Hori, K., K. Matsubara, and K. Miyazawa. 2000. Primary structures of two hemagglutinins from the marine red alga, Hypnea japonica. Biochimica et Biophysica Acta (Bba) - General Subjects 1474 (2):226–36. doi: 10.1016/S0304-4165(00)00008-8.
  • Hsu, K.-C., E. C. Li-Chan, and C.-L. Jao. 2011. Antiproliferative activity of peptides prepared from enzymatic hydrolysates of tuna dark muscle on human breast cancer cell line MCF-7. Food Chemistry 126 (2):617–22. doi: 10.1016/j.foodchem.2010.11.066.
  • Isaka, M., U. Srisanoh, N. Lartpornmatulee, and T. Boonruangprapa. 2007. ES-242 derivatives and cycloheptapeptides from Cordyceps sp. strains BCC 16173 and BCC 16176. Journal of Natural Products 70 (10):1601–4. doi: 10.1021/np070357h.
  • Je, J.-Y., J.-Y. Park, W.-K. Jung, P.-J. Park, and S.-K. Kim. 2005a. Isolation of angiotensin I converting enzyme (ACE) inhibitor from fermented oyster sauce, Crassostrea gigas. Food Chemistry 90 (4):809–14. doi: 10.1016/j.foodchem.2004.05.028.
  • Je, J.-Y., P.-J. Park, and S.-K. Kim. 2005b. Antioxidant activity of a peptide isolated from Alaska pollack (Theragra chalcogramma) frame protein hydrolysate. Food Research International 38 (1):45–50. doi: 10.1016/j.foodres.2004.07.005.
  • Je, J.-Y., Z.-J. Qian, H.-G. Byun, and S.-K. Kim. 2007. Purification and characterization of an antioxidant peptide obtained from tuna backbone protein by enzymatic hydrolysis. Process Biochemistry 42 (5):840–6. doi: 10.1016/j.procbio.2007.02.006.
  • Je, J.-Y., Z.-J. Qian, S.-H. Lee, H.-G. Byun, and S.-K. Kim. 2008. Purification and antioxidant properties of bigeye tuna (Thunnus obesus) dark muscle peptide on free radical-mediated oxidative systems. Journal of Medicinal Food 11 (4):629–37. doi: 10.1089/jmf.2007.0114.
  • Jo, H.-Y., W.-K. Jung, and S.-K. Kim. 2008. Purification and characterization of a novel anticoagulant peptide from marine echiuroid worm, Urechis unicinctus. Process Biochemistry 43 (2):179–84. doi: 10.1016/j.procbio.2007.11.011.
  • Jo, C., F. F. Khan, M. I. Khan, and J. Iqbal. 2017. Marine bioactive peptides: Types, structures, and physiological functions. Food Reviews International 33 (1):44–61. doi: 10.1080/87559129.2015.1137311.
  • Jun, S.-Y., P.-J. Park, W.-K. Jung, and S.-K. Kim. 2004. Purification and characterization of an antioxidative peptide from enzymatic hydrolysate of yellowfin sole (Limanda aspera) frame protein. European Food Research and Technology 219 (1):20–6. doi: 10.1007/s00217-004-0882-9.
  • Jung, W.-K., R. Karawita, S.-J. Heo, B.-J. Lee, S.-K. Kim, and Y.-J. Jeon. 2006a. Recovery of a novel Ca-binding peptide from Alaska Pollack (Theragra chalcogramma) backbone by pepsinolytic hydrolysis. Process Biochemistry 41 (9):2097–100. doi: 10.1016/j.procbio.2006.05.008.
  • Jung, W.-K., and S.-K. Kim. 2007. Calcium-binding peptide derived from pepsinolytic hydrolysates of hoki (Johnius belengerii) frame. European Food Research and Technology 224 (6):763–7. doi: 10.1007/s00217-006-0371-4.
  • Jung, W.-K., E. Mendis, J.-Y. Je, P.-J. Park, B. W. Son, H. C. Kim, Y. K. Choi, and S.-K. Kim. 2006b. Angiotensin I-converting enzyme inhibitory peptide from yellowfin sole (Limanda aspera) frame protein and its antihypertensive effect in spontaneously hypertensive rats. Food Chemistry 94 (1):26–32. doi: 10.1016/j.foodchem.2004.09.048.
  • Jung, W.-K., Z.-J. Qian, S.-H. Lee, S. Y. Choi, N. J. Sung, H.-G. Byun, and S.-K. Kim. 2007. Free radical scavenging activity of a novel antioxidative peptide isolated from in vitro gastrointestinal digests of Mytilus coruscus. Journal of Medicinal Food 10 (1):197–202. doi: 10.1089/jmf.2006.101.
  • Kalemkerian, G. P., X. Ou, M. R. Adil, R. Rosati, M. M. Khoulani, S. K. Madan, and G. R. Pettit. 1999. Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: Induction of apoptosis and bcl-2 modification. Cancer Chemotherapy and Pharmacology 43 (6):507–15. doi: 10.1007/s002800050931.
  • Kannel, W., and M. Higgins. 1990. Smoking and hypertension as predictors of cardiovascular risk in population studies. Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 8:S3–S8.
  • Khan, B. M., and Y. Liu. 2019. Marine mollusks: Food with benefits. Comprehensive Reviews in Food Science and Food Safety 18 (2):548–64. doi: 10.1111/1541-4337.12429.
  • Kim, S.-Y., J.-Y. Je, and S.-K. Kim. 2007. Purification and characterization of antioxidant peptide from hoki (Johnius belengerii) frame protein by gastrointestinal digestion. The Journal of Nutritional Biochemistry 18 (1):31–8. doi: 10.1016/j.jnutbio.2006.02.006.
  • Kobayashi, M., S. Aoki, N. Ohyabu, M. Kurosu, W. Wang, and I. Kitagawa. 1994. Arenastatin A, a potent cytotoxic depsipeptide from the Okinawan marine sponge Dysidea arenaria. Tetrahedron Letters 35 (41):7969–72. doi: 10.1016/S0040-4039(00)78398-5.
  • Kristinsson, H. G., and H. O. Hultin. 2003. Effect of low and high pH treatment on the functional properties of cod muscle proteins. Journal of Agricultural and Food Chemistry 51 (17):5103–10. doi: 10.1021/jf026138d.
  • Kristinsson, H. G., and B. Ingadottir. 2006. Recovery and properties of muscle proteins extracted from tilapia (Oreochromis niloticus) light muscle by pH shift processing. Journal of Food Science 71 (3):E132–E141. doi: 10.1111/j.1365-2621.2006.tb15626.x.
  • Kristinsson, H. G., A. E. Theodore, N. Demir, and B. Ingadottir. 2006. A comparative study between acid‐and alkali‐aided processing and surimi processing for the recovery of proteins from channel catfish muscle. Journal of Food Science 70 (4):C298–C306. doi: 10.1111/j.1365-2621.2005.tb07177.x.
  • Kucuk, O., M. L. Young, T. M. Habermann, B. C. Wolf, J. Jimeno, and P. A. Cassileth. 2000. Phase II trail of didemnin B in previously treated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group (ECOG) Study. American Journal of Clinical Oncology 23 (3):273–7. doi: 10.1097/00000421-200006000-00013.
  • Kumar, N. S., R. Nazeer, and R. Jaiganesh. 2011. Purification and biochemical characterization of antioxidant peptide from horse mackerel (Magalaspis cordyla) viscera protein. Peptides 32 (7):1496–501. doi: 10.1016/j.peptides.2011.05.020.
  • Lee, J. K., S. Hong, J.-K. Jeon, S.-K. Kim, and H.-G. Byun. 2009. Purification and characterization of angiotensin I converting enzyme inhibitory peptides from the rotifer, Brachionus rotundiformis. Bioresource Technology 100 (21):5255–9. doi: 10.1016/j.biortech.2009.05.057.
  • Lee, J.-W., and T. W. Jeffries. 2011. Efficiencies of acid catalysts in the hydrolysis of lignocellulosic biomass over a range of combined severity factors. Bioresource Technology 102 (10):5884–90. doi: 10.1016/j.biortech.2011.02.048.
  • Lee, T.-G., and S. Maruyama. 1998. Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins. Biochemical and Biophysical Research Communications 253 (3):604–8. doi: 10.1006/bbrc.1998.9824.
  • Lee, J.-Y., B. Orlikova, and M. Diederich. 2015. Signal transducers and activators of transcription (STAT) regulatory networks in marine organisms: From physiological observations towards marine drug discovery. Marine Drugs 13 (8):4967–84. doi: 10.3390/md13084967.
  • Lee, Y., C. Phat, and S.-C. Hong. 2017. Structural diversity of marine cyclic peptides and their molecular mechanisms for anticancer, antibacterial, antifungal, and other clinical applications. Peptides 95:94–105. doi: 10.1016/j.peptides.2017.06.002.
  • Lee, S.-H., Z.-J. Qian, and S.-K. Kim. 2010. A novel angiotensin I converting enzyme inhibitory peptide from tuna frame protein hydrolysate and its antihypertensive effect in spontaneously hypertensive rats. Food Chemistry 118 (1):96–102. doi: 10.1016/j.foodchem.2009.04.086.
  • Liang, X., X.-Y. Zhang, X.-H. Nong, J. Wang, Z.-H. Huang, and S.-H. Qi. 2016. Eight linear peptides from the deep-sea-derived fungus Simplicillium obclavatum EIODSF 020. Tetrahedron 72 (22):3092–7. doi: 10.1016/j.tet.2016.04.032.
  • Li, G.-H., G.-W. Le, Y.-H. Shi, and S. Shrestha. 2004. Angiotensin I–converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutrition Research 24 (7):469–86. doi: 10.1016/S0271-5317(04)00058-2.
  • Ling, Y.-H., M. Aracil, J. Jimeno, R. Perez-Soler, and Y. Zou. 2009. Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib; synergistic activity in human non-small cell lung cancer cell lines and xenograft models. European Journal of Cancer (Oxford, England : 1990) 45 (10):1855–64. doi: 10.1016/j.ejca.2009.03.003.
  • Lin, Z., C. A. Reilly, R. Antemano, R. W. Hughen, L. Marett, G. P. Concepcion, M. G. Haygood, B. M. Olivera, A. Light, and E. W. Schmidt. 2011. Nobilamides A-H, long-acting transient receptor potential vanilloid-1 (TRPV1) antagonists from mollusk-associated bacteria . Journal of Medicinal Chemistry 54 (11):3746–55. doi: 10.1021/jm101621u.
  • Liu, S., Y.-M. Cui, and F.-J. Nan. 2008a. Total synthesis of the originally proposed and revised structures of scleritodermin A. Organic Letters 10 (17):3765–8. doi: 10.1021/ol801419m.
  • Liu, Z., S. Dong, J. Xu, M. Zeng, H. Song, and Y. Zhao. 2008b. Production of cysteine-rich antimicrobial peptide by digestion of oyster (Crassostrea gigas) with alcalase and bromelin. Food Control 19 (3):231–5. doi: 10.1016/j.foodcont.2007.03.004.
  • Liu, L., and K. S. Rein. 2010. New peptides isolated from Lyngbya species: A review. Marine Drugs 8 (6):1817–37. doi: 10.3390/md8061817.
  • Li, W.-L., Y.-H. Yi, H.-M. Wu, Q.-Z. Xu, H.-F. Tang, D.-Z. Zhou, H.-W. Lin, and Z.-H. Wang. 2003. Isolation and structure of the cytotoxic cycloheptapeptide phakellistatin 13. Journal of Natural Products 66 (1):146–8. doi: 10.1021/np020223y.
  • Li, Y., and J. Yu. 2015. Research progress in structure-activity relationship of bioactive peptides. Journal of Medicinal Food 18 (2):147–56. doi: 10.1089/jmf.2014.0028.
  • Loganzo, F., C. M. Discafani, T. Annable, C. Beyer, S. Musto, M. Hari, X. Tan, C. Hardy, R. Hernandez, M. Baxter, et al. 2003. HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo. Cancer Research 63 (8):1838–45.
  • Loow, Y.-L., T. Y. Wu, J. M. Jahim, A. W. Mohammad, and W. H. Teoh. 2016. Typical conversion of lignocellulosic biomass into reducing sugars using dilute acid hydrolysis and alkaline pretreatment. Cellulose 23 (3):1491–520. doi: 10.1007/s10570-016-0936-8.
  • Ma, D., B. Zou, G. Cai, X. Hu, and J. O. Liu. 2006. Total synthesis of the cyclodepsipeptide apratoxin A and its analogues and assessment of their biological activities. Chemistry (Weinheim an der Bergstrasse, Germany) 12 (29):7615–26. doi: 10.1002/chem.200600599.
  • MacMillan, J. B., M. A. Ernst-Russell, J. S. De Ropp, and T. F. Molinski. 2002. Lobocyclamides A − C, Lipopeptides from a cryptic cyanobacterial mat containing Lyngbya c onfervoides. The Journal of Organic Chemistry 67 (23):8210–5. doi: 10.1021/jo0261909.
  • Madden, T., H. T. Tran, D. Beck, R. Huie, R. A. Newman, L. Pusztai, J. J. Wright, and J. L. Abbruzzese. 2000. Novel marine-derived anticancer agents: A phase I clinical, pharmacological, and pharmacodynamic study of dolastatin 10 (NSC 376128) in patients with advanced solid tumors. Clinical Cancer Research 6:1293–301.
  • Malaker, A., and S. A. I. Ahmad. 2013. Therapeutic potency of anticancer peptides derived from marine organism. International Journal of Engineering 2:2305–8269.
  • Marcos, B., T. Aymerich, J. M. Monfort, and M. Garriga. 2008. High-pressure processing and antimicrobial biodegradable packaging to control Listeria monocytogenes during storage of cooked ham. Food Microbiology 25 (1):177–82. doi: 10.1016/j.fm.2007.05.002.
  • Marquez, B. L., K. S. Watts, A. Yokochi, M. A. Roberts, P. Verdier-Pinard, J. I. Jimenez, E. Hamel, P. J. Scheuer, and W. H. Gerwick. 2002. Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly. Journal of Natural Products 65 (6):866–71. doi: 10.1021/np0106283.
  • Mateos, M. V., M. T. Cibeira, P. G. Richardson, F. Prosper, A. Oriol, J. de la Rubia, J. J. Lahuerta, R. García-Sanz, S. Extremera, S. Szyldergemajn, et al. 2010. Phase II clinical and pharmacokinetic study of plitidepsin 3-hour infusion every two weeks alone or with dexamethasone in relapsed and refractory multiple myeloma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16 (12):3260–9. doi: 10.1158/1078-0432.CCR-10-0469.
  • Matsunaga, S., and N. Fusetani. 2003. Nonribosomal peptides from marine sponges. Current Organic Chemistry 7 (10):945–66. doi: 10.2174/1385272033486648.
  • Matsunaga, S., N. Fusetani, and S. Konosu. 1984. Bioactive marine metabolites VI. Structure elucidation of discodermin A, an antimicrobial peptide from the marine sponge Discodermia kiiensis. Tetrahedron Letters 25 (45):5165–8. doi: 10.1016/S0040-4039(01)81553-7.
  • Matsunaga, S., N. Fusetani, and S. Konosu. 1985. Bioactive marine metabolites VII. Structures of discodermins B, C, and D, antimicrobial peptides from the marine sponge discodermia kiiensis. Tetrahedron Letters 26 (7):855–6. doi: 10.1016/S0040-4039(00)61947-0.
  • Mayer, A. M., K. B. Glaser, C. Cuevas, R. S. Jacobs, W. Kem, R. D. Little, J. M. McIntosh, D. J. Newman, B. C. Potts, and D. E. Shuster. 2010. The odyssey of marine pharmaceuticals: A current pipeline perspective. Trends in Pharmacological Sciences 31 (6):255–65. doi: 10.1016/j.tips.2010.02.005.
  • McIntosh, M., L. Cruz, M. Hunkapiller, W. Gray, and B. Olivera. 1982. Isolation and structure of a peptide toxin from the marine snail Conus magus. Archives of Biochemistry and Biophysics 218 (1):329–34. doi: 10.1016/0003-9861(82)90351-4.
  • Mechnich, O., and H. Kessler. 1997. What are the structures of phakellistatin 2 and phakellistatin 4? Letters in Peptide Science 4 (1):21–8. doi: 10.1007/BF02443551.
  • Medina, R. A., D. E. Goeger, P. Hills, S. L. Mooberry, N. Huang, L. I. Romero, E. Ortega-Barría, W. H. Gerwick, and K. L. McPhail. 2008. Coibamide A, a potent antiproliferative cyclic depsipeptide from the Panamanian marine cyanobacterium Leptolyngbya sp. Journal of the American Chemical Society 130 (20):6324–5. doi: 10.1021/ja801383f.
  • Mendis, E., N. Rajapakse, H.-G. Byun, and S.-K. Kim. 2005a. Investigation of jumbo squid (Dosidicus gigas) skin gelatin peptides for their in vitro antioxidant effects. Life Sciences 77 (17):2166–78. doi: 10.1016/j.lfs.2005.03.016.
  • Mendis, E., N. Rajapakse, and S.-K. Kim. 2005b. Antioxidant properties of a radical-scavenging peptide purified from enzymatically prepared fish skin gelatin hydrolysate. Journal of Agricultural and Food Chemistry 53 (3):581–7. doi: 10.1021/jf048877v.
  • Miguel, M., M. Contreras, I. Recio, and A. Aleixandre. 2009. ACE-inhibitory and antihypertensive properties of a bovine casein hydrolysate. Food Chemistry 112 (1):211–4. doi: 10.1016/j.foodchem.2008.05.041.
  • Miljanich, G. 2004. Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain. Current Medicinal Chemistry 11 (23):3029–40. doi: 10.2174/0929867043363884.
  • Mittelman, A., H. G. Chun, C. Puccio, N. Coombe, T. Lansen, and T. Ahmed. 1999. Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or glioblastoma multiforme (NSC 325319). Investigational New Drugs 17 (2):179–82. doi: 10.1023/a:1006379402114.
  • Möller, N. P., K. E. Scholz-Ahrens, N. Roos, and J. Schrezenmeir. 2008. Bioactive peptides and proteins from foods: Indication for health effects. European Journal of Nutrition 47 (4):171–82. doi: 10.1007/s00394-008-0710-2.
  • Mooberry, S. L., R. M. Leal, T. L. Tinley, H. Luesch, R. E. Moore, and T. H. Corbett. 2003. The molecular pharmacology of symplostatin 1: A new antimitotic dolastatin 10 analog. International Journal of Cancer 104 (4):512–21. doi: 10.1002/ijc.10982.
  • Najafian, L., and A. Babji. 2012. A review of fish-derived antioxidant and antimicrobial peptides: Their production, assessment, and applications. Peptides 33 (1):178–85. doi: 10.1016/j.peptides.2011.11.013.
  • Nakagomi, K., A. Fujimura, H. Ebisu, T. Sakai, Y. Sadakane, N. Fujii, and T. Tanimura. 1998. Acein-1, a novel angiotensin-I-converting enzyme inhibitory peptide isolated from tryptic hydrolysate of human plasma. FEBS Letters 438 (3):255–7. doi: 10.1016/s0014-5793(98)01311-8.
  • Nakagomi, K., R. Yamada, H. Ebisu, Y. Sadakane, T. Akizawa, and T. Tanimura. 2000. Isolation of Acein-2, a novel angiotensin-I-converting enzyme inhibitory peptide derived from a tryptic hydrolysate of human plasma. FEBS Letters 467 (2–3):235–8. doi: 10.1016/s0014-5793(00)01163-7.
  • Nakashima, Y., Y. Egami, M. Kimura, T. Wakimoto, and I. Abe. 2016. Metagenomic analysis of the sponge Discodermia reveals the production of the cyanobacterial natural product kasumigamide by 'Entotheonella'. PLoS One 11 (10):e0164468. doi: 10.1371/journal.pone.0164468.
  • Newman, D. J., and G. M. Cragg. 2004. Advanced preclinical and clinical trials of natural products and related compounds from marine sources. Current Medicinal Chemistry 11 (13):1693–713. doi: 10.2174/0929867043364982.
  • Newman, D. J., and G. M. Cragg. 2014. Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development. Marine Drugs 12 (1):255–78. doi: 10.3390/md12010255.
  • Ngo, D.-H., and S.-K. Kim. 2013. Marine bioactive peptides as potential antioxidants. Current Protein & Peptide Science 14 (3):189–98. doi: 10.2174/13892037113149990041.
  • Ngo, D.-H., T.-S. Vo, D.-N. Ngo, I. Wijesekara, and S.-K. Kim. 2012. Biological activities and potential health benefits of bioactive peptides derived from marine organisms. International Journal of Biological Macromolecules 51 (4):378–83. doi: 10.1016/j.ijbiomac.2012.06.001.
  • Nielsen, C. K., R. J. Lewis, D. Alewood, R. Drinkwater, E. Palant, M. Patterson, T. L. Yaksh, D. McCumber, and M. T. Smith. 2005. Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic pain. Pain 118 (1–2):112–24. doi: 10.1016/j.pain.2005.08.002.
  • Nogle, L. M., B. L. Marquez, and W. H. Gerwick. 2003. Wewakazole, a novel cyclic dodecapeptide from a Papua New Guinea Lyngbya m ajuscula. Organic Letters 5 (1):3–6. doi: 10.1021/ol026811k.
  • Odaka, C., M. L. Sanders, and P. Crews. 2000. Jasplakinolide induces apoptosis in various transformed cell lines by a caspase-3-like protease-dependent pathway. Clinical and Diagnostic Laboratory Immunology 7 (6):947–52. doi: 10.1128/cdli.7.6.947-952.2000.
  • Oku, N., K. R. Gustafson, L. K. Cartner, J. A. Wilson, N. Shigematsu, S. Hess, L. K. Pannell, M. R. Boyd, and J. B. McMahon. 2004. Neamphamide A, a new HIV-inhibitory depsipeptide from the Papua New Guinea marine sponge Neamphius huxleyi. Journal of Natural Products 67 (8):1407–11. doi: 10.1021/np040003f.
  • Oku, N., R. Krishnamoorthy, A. G. Benson, R. L. Ferguson, M. A. Lipton, L. R. Phillips, K. R. Gustafson, and J. B. McMahon. 2005. Complete stereochemistry of neamphamide A and absolute configuration of the beta-methoxytyrosine residue in papuamide B. The Journal of Organic Chemistry 70 (17):6842–7. doi: 10.1021/jo0508853.
  • Olivera, B. M., W. R. Gray, R. Zeikus, J. M. McIntosh, J. Varga, J. Rivier, V. De Santos, and L. J. Cruz. 1985. Peptide neurotoxins from fish-hunting cone snails. Science (New York, N.Y.) 230 (4732):1338–43. doi: 10.1126/science.4071055.
  • Ott, P. A., O. Hamid, A. C. Pavlick, H. Kluger, K. B. Kim, P. D. Boasberg, R. Simantov, E. Crowley, J. A. Green, T. Hawthorne, et al. 2014. Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 32 (32):3659–66. doi: 10.1200/JCO.2013.54.8115.
  • Ovissipour, M., A. Abedian, A. Motamedzadegan, B. Rasco, R. Safari, and H. Shahiri. 2009. The effect of enzymatic hydrolysis time and temperature on the properties of protein hydrolysates from Persian sturgeon (Acipenser persicus) viscera. Food Chemistry 115 (1):238–42. doi: 10.1016/j.foodchem.2008.12.013.
  • Pelay-Gimeno, M., A. Meli, J. Tulla-Puche, and F. Albericio. 2013. Rescuing biological activity from synthetic phakellistatin 19. Journal of Medicinal Chemistry 56 (23):9780–8. doi: 10.1021/jm401520x.
  • Perez Espitia, P. J., N. de Fátima Ferreira Soares, J. S. dos Reis Coimbra, N. J. de Andrade, R. Souza Cruz, and E. A. A. Medeiros. 2012. Bioactive peptides: Synthesis, properties, and applications in the packaging and preservation of food. Comprehensive Reviews in Food Science and Food Safety 11 (2):187–204. doi: 10.1111/j.1541-4337.2011.00179.x.
  • Pettit, G. R., Z. Cichacz, J. Barkoczy, A.-C. Dorsaz, D. L. Herald, M. D. Williams, D. L. Doubek, J. M. Schmidt, L. P. Tackett, and D. C. Brune. 1993. Isolation and structure of the marine sponge cell growth inhibitory cyclic peptide phakellistatin 1. Journal of Natural Products 56 (2):260–7. doi: 10.1021/np50092a011.
  • Pettit, G. R., M. R. Rhodes, and R. Tan. 1999. Antineoplastic Agents. 400. Synthesis of the Indian Ocean marine sponge cyclic heptapeptide Phakellistatin 2, 1a. Journal of Natural Products 62 (3):409–14. doi: 10.1021/np980168m.
  • Pettit, G. R., S. B. Singh, F. Hogan, P. Lloyd-Williams, D. L. Herald, D. D. Burkett, and P. J. Clewlow. 1989. Antineoplastic agents. Part 189. The absolute configuration and synthesis of natural (-)-dolastatin 10. Journal of the American Chemical Society 111 (14):5463–5. doi: 10.1021/ja00196a061.
  • Pettit, G. R., and R. Tan. 2003. Antineoplastic agents 390. Isolation and structure of phakellistatin 12 from a Chuuk archipelago marine sponge. Bioorganic & Medicinal Chemistry Letters 13 (4):685–8. doi: 10.1016/S0960-894X(02)01054-5.
  • Pettit, G. R., and R. Tan. 2005. Isolation and structure of Phakellistatin 14 from the Western Pacific marine sponge Phakellia sp., 1. Journal of Natural Products 68 (1):60–3. doi: 10.1021/np040092w.
  • Pettit, G. R., R. Tan, D. L. Herald, M. D. Williams, and R. L. Cerny. 1994a. Antineoplastic agents. 277. Isolation and structure of phakellistatin 3 and isophakellistatin 3 from a Republic of Comoros marine sponge. The Journal of Organic Chemistry 59 (7):1593–5. doi: 10.1021/jo00086a001.
  • Pettit, G. R., R. Tan, Y. Ichihara, M. D. Williams, D. L. Doubek, L. P. Tackett, J. M. Schmidt, R. L. Cerny, M. R. Boyd, and J. N. Hooper. 1995a. Antineoplastic agents, 325. Isolation and structure of the human cancer cell growth inhibitory cyclic octapeptides phakellistatin 10 and 11 from Phakellia sp. Journal of Natural Products 58 (6):961–5. doi: 10.1021/np50120a025.
  • Pettit, G. R., J.-P. Xu, Z. Cichacz, J. M. Achmidt, A.-C. Dorsaz, M. R. Boyd, and R. L. Cerny. 1995b. Isolation and structure of the human cancer cell growth inhibitory phakellistatin 4 from the western Pacific sponge Phakellia costata. Heterocycles 40 (2):501–6. doi: 10.3987/COM-94-S45.
  • Pettit, G. R., J.-P. Xu, Z. A. Cichacz, M. D. Williams, J.-C. Chapuis, and R. L. Cerny. 1994b. Antineoplastic agents 323. Isolation and structure of phakellistatin 6 from a Chuuk archipelago marine sponge. Bioorganic & Medicinal Chemistry Letters 4 (22):2677–82. doi: 10.1016/S0960-894X(01)80695-8.
  • Pettit, G. R., J.-p. Xu, Z. A. Cichacz, M. D. Williams, A.-C. Dorsaz, D. C. Brune, M. R. Boyd, and R. L. Cerny. 1994c. Antineoplastic agents 315. Isolation and structure of the marine sponge cancer cell growth inhibitor phakellistatin 5. Bioorganic & Medicinal Chemistry Letters 4 (17):2091–6. doi: 10.1016/S0960-894X(01)80108-6.
  • Pettit, G. R., J.-p. Xu, A.-C. Dorsaz, M. D. Williams, M. R. Boyd, and R. L. Cerny. 1995c. Isolation and structure of the human cancer cell growth inhibitory cyclic decapeptides phakellistatins 7, 8 and 91, 2. Bioorganic & Medicinal Chemistry Letters 5 (13):1339–44. doi: 10.1016/0960-894X(95)00219-J.
  • Picot, L., S. Bordenave, S. Didelot, I. Fruitier-Arnaudin, F. Sannier, G. Thorkelsson, J. Bergé, F. Guérard, A. Chabeaud, and J. Piot. 2006. Antiproliferative activity of fish protein hydrolysates on human breast cancer cell lines. Process Biochemistry 41 (5):1217–22. doi: 10.1016/j.procbio.2005.11.024.
  • Plaza, A., G. Bifulco, J. L. Keffer, J. R. Lloyd, H. L. Baker, and C. A. Bewley. 2009. Celebesides A − C and theopapuamides B − D, depsipeptides from an Indonesian sponge that inhibit HIV-1 entry. The Journal of Organic Chemistry 74 (2):504–12. doi: 10.1021/jo802232u.
  • Plaza, A., E. Gustchina, H. L. Baker, M. Kelly, and C. A. Bewley. 2007. Mirabamides A–D, depsipeptides from the sponge Siliquariaspongia mirabilis that inhibit HIV-1 fusion. Journal of Natural Products 70 (11):1753–60. doi: 10.1021/np070306k.
  • Plummer, R., P. Lorigan, E. Brown, R. Zaucha, V. Moiseyenko, L. Demidov, V. Soriano, E. Chmielowska, R. Andrés, G. Kudryavtseva, et al. 2013. Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma. British Journal of Cancer 109 (6):1451–9. doi: 10.1038/bjc.2013.477.
  • Pomponi, S. A. 2001. The Rogar Revelle commemorative lecture: The oceans and human health: The discovery and development of marine-derived drugs. Oceanography 14 (1):78–87. doi: 10.5670/oceanog.2001.53.
  • Qian, Z.-J., J.-Y. Je, and S.-K. Kim. 2007. Antihypertensive effect of angiotensin I converting enzyme-inhibitory peptide from hydrolysates of bigeye tuna dark muscle, Thunnus obesus. Journal of Agricultural and Food Chemistry 55 (21):8398–403. doi: 10.1021/jf0710635.
  • Qian, Z.-J., W.-K. Jung, H.-G. Byun, and S.-K. Kim. 2008. Protective effect of an antioxidative peptide purified from gastrointestinal digests of oyster, Crassostrea gigas against free radical induced DNA damage. Bioresource Technology 99 (9):3365–71. doi: 10.1016/j.biortech.2007.08.018.
  • Rajapakse, N., E. Mendis, H.-G. Byun, and S.-K. Kim. 2005a. Purification and in vitro antioxidative effects of giant squid muscle peptides on free radical-mediated oxidative systems. The Journal of Nutritional Biochemistry 16 (9):562–9. doi: 10.1016/j.jnutbio.2005.02.005.
  • Rajapakse, N., E. Mendis, W.-K. Jung, J.-Y. Je, and S.-K. Kim. 2005b. Purification of a radical scavenging peptide from fermented mussel sauce and its antioxidant properties. Food Research International 38 (2):175–82. doi: 10.1016/j.foodres.2004.10.002.
  • Ranathunga, S., N. Rajapakse, and S.-K. Kim. 2006. Purification and characterization of antioxidative peptide derived from muscle of conger eel (Conger myriaster). European Food Research and Technology 222 (3–4):310–5. doi: 10.1007/s00217-005-0079-x.
  • Rangel, M., M. P. Prado, K. Konno, H. Naoki, J. C. Freitas, and G. M. Machado-Santelli. 2006. Cytoskeleton alterations induced by Geodia corticostylifera depsipeptides in breast cancer cells. Peptides 27 (9):2047–57. doi: 10.1016/j.peptides.2006.04.021.
  • Rashid, M. A., K. R. Gustafson, L. K. Cartner, N. Shigematsu, L. K. Pannell, and M. R. Boyd. 2001. Microspinosamide, a New HIV-inhibitory cyclic depsipeptide from the marine sponge sidonops m icrospinosa. Journal of Natural Products 64 (1):117–21. doi: 10.1021/np0002379.
  • Raymond, E., N. Ady-Vago, E. Baudin, V. Ribrag, S. Faivre, F. Lecot, T. Wright, L. Lazaro, C. Guzman, and J. Jimeno. 2000. A phase I and pharmacokinetic study of aplidine (APL) given as a 24-hour continuous infusion every other week (q2w) in patients (pts) with solid tumor (ST) and lymphoma (NHL). Proceedings 11th NCI-EORTC-AACR Symposium 2000. Amsterdam. 7–10 November, p. 86.
  • Rho, S. J., J.-S. Lee, Y. I. Chung, Y.-W. Kim, and H. G. Lee. 2009. Purification and identification of an angiotensin I-converting enzyme inhibitory peptide from fermented soybean extract. Process Biochemistry 44 (4):490–3. doi: 10.1016/j.procbio.2008.12.017.
  • Ribrag, V., D. Caballero, C. Ferme, E. Zucca, R. Arranz, J. Briones, C. Gisselbrecht, G. Salles, A. M. Gianni, H. Gomez, et al. 2013. Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin’s lymphoma. haematologica 98 (3):357–63. doi: 10.3324/haematol.2012.069757.
  • Richard, N. L., L. F. Pivarnik, P. C. Ellis, and C. M. Lee. 2011. Impact of quality parameters on the recovery of putrescine and cadaverine in fish using methanol-hydrochloric acid solvent extraction. Journal of AOAC International 94 (4):1177–88.
  • Rudi, A., L. Chill, M. Aknin, and Y. Kashman. 2003. Didmolamide A and B, two new cyclic hexapeptides from the marine ascidian Didemnum m olle. Journal of Natural Products 66 (4):575–7. doi: 10.1021/np020531w.
  • Ryu, G., S. Matsunaga, and N. Fusetani. 1994a. Discodermin E, a cytotoxic and antimicrobial tetradecapeptide, from the marine sponge Discodermia kiiensis. Tetrahedron Letters 35 (44):8251–4. doi: 10.1016/0040-4039(94)88295-9.
  • Ryu, G., S. Matsunaga, and N. Fusetani. 1994b. Discodermins FH, cytotoxic and antimicrobial tetradecapeptides from the marine sponge Discodermia kiiensis: Structure revision of discodermins AD. Tetrahedron 50 (47):13409–16. doi: 10.1016/S0040-4020(01)89347-9.
  • Sagar, S., M. Kaur, and K. P. Minneman. 2010. Antiviral lead compounds from marine sponges. Marine Drugs 8 (10):2619–38. doi: 10.3390/md8102619.
  • Saidi, S., M.-P. Belleville, A. Deratani, and R. Ben Amar. 2016. Production of interesting peptide fractions by enzymatic hydrolysis of tuna dark muscle by-product using alcalase. Journal of Aquatic Food Product Technology 25 (2):251–64. doi: 10.1080/10498850.2013.844753.
  • Sakai, R., J. G. Stroh, D. W. Sullins, and K. L. Rinehart. 1995. Seven new didemnins from the marine tunicate Trididemnum solidum. Journal of the American Chemical Society 117 (13):3734–48. doi: 10.1021/ja00118a010.
  • Salazar, R., R. J. Jones, A. Oaknin, D. Crawford, C. Cuadra, C. Hopkins, M. Gil, C. Coronado, A. Soto-Matos, M. Cullell-Young, et al. 2012. A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology 70 (5):673–81. doi: 10.1007/s00280-012-1951-6.
  • Sánchez, A., and A. Vázquez. 2017. Bioactive peptides: A review. Food Quality and Safety 1 (1):29–46. doi: 10.1093/fqsafe/fyx006.
  • Sarmadi, B. H., and A. Ismail. 2010. Antioxidative peptides from food proteins: A review. Peptides 31 (10):1949–56. doi: 10.1016/j.peptides.2010.06.020.
  • Sasaki, H., T. Teruya, H. Fukazawa, and K. Suenaga. 2011. Revised structure and structure–activity relationship of bisebromoamide and structure of norbisebromoamide from the marine cyanobacterium Lyngbya sp. Tetrahedron 67 (5):990–4. doi: 10.1016/j.tet.2010.11.106.
  • Schmidt, E. W., C. Raventos-Suarez, M. Bifano, A. T. Menendez, C. R. Fairchild, and D. J. Faulkner. 2004. Scleritodermin A, a cytotoxic cyclic peptide from the lithistid sponge Scleritoderma nodosum. Journal of Natural Products 67 (3):475–8. doi: 10.1021/np034035z.
  • Sekar, S., and M. Chandramohan. 2008. Phycobiliproteins as a commodity: Trends in applied research, patents and commercialization. Journal of Applied Phycology 20 (2):113–36. doi: 10.1007/s10811-007-9188-1.
  • Senevirathne, M., and S.-K. Kim. 2012. Development of bioactive peptides from fish proteins and their health promoting ability. Advances in Food and Nutrition Research 65:235–48. doi: 10.1016/B978-0-12-416003-3.00015-9.
  • Serova, M., A. de Gramont, I. Bieche, M. E. Riveiro, C. M. Galmarini, M. Aracil, J. Jimeno, S. Faivre, and E. Raymond. 2013. Predictive factors of sensitivity to elisidepsin, a novel Kahalalide F-derived marine compound. Marine Drugs 11 (3):944–59. doi: 10.3390/md11030944.
  • Shaheen, F., M. A. Ziaee, S. A. Ali, S. U. Simjee, A. Ahmed, and M. I. Choudhary. 2016. The first solid-phase synthesis and structural studies on Phakellistatin 15. Records of Natural Products 10:397–406.
  • Shukla, S. 2016. Therapeutic importance of peptides from marine source: A mini review. Indian Journal of Geo-Marine Sciences 45 (11):1422–1431.
  • Siro, I., E. Kápolna, B. Kápolna, and A. Lugasi. 2008. Functional food. Product development, marketing and consumer acceptance—A review. Appetite 51 (3):456–67. doi: 10.1016/j.appet.2008.05.060.
  • Sone, H., T. Kondo, M. Kiryu, H. Ishiwata, M. Ojika, and K. Yamada. 1995. Dolabellin, a cytotoxic bisthiazole metabolite from the sea hare Dolabella auricularia: Structural determination and synthesis. The Journal of Organic Chemistry 60 (15):4774–81. doi: 10.1021/jo00120a021.
  • Song, R., R. Wei, B. Zhang, and D. Wang. 2012. Optimization of the antibacterial activity of half-fin anchovy (Setipinna taty) hydrolysates. Food and Bioprocess Technology 5 (5):1979–89. doi: 10.1007/s11947-010-0505-3.
  • Stensvåg, K., T. Haug, S. V. Sperstad, Ø. Rekdal, B. Indrevoll, and O. B. Styrvold. 2008. Arasin 1, a proline-arginine-rich antimicrobial peptide isolated from the spider crab, Hyas araneus. Developmental and Comparative Immunology 32 (3):275–85. doi: 10.1016/j.dci.2007.06.002.
  • Sugahara, T., Y. Ohama, A. Fukuda, M. Hayashi, A. Kawakubo, and K. Kato. 2001. The cytotoxic effect of Eucheuma serra agglutinin (ESA) on cancer cells and its application to molecular probe for drug delivery system using lipid vesicles. Cytotechnology 36 (1–3):93–9.
  • Swersey, J. C., C. M. Ireland, L. M. Cornell, and R. W. Peterson. 1994. Eusynstyelamide, a highly modified dimer peptide from the ascidian Eusynstyela misakiensis. Journal of Natural Products 57 (6):842–5. doi: 10.1021/np50108a027.
  • Talpir, R., Y. Benayahu, Y. Kashman, L. Pannell, and M. Schleyer. 1994. Hemiasterlin and geodiamolide TA; two new cytotoxic peptides from the marine sponge Hemiasterella minor (Kirkpatrick). Tetrahedron Letters 35 (25):4453–6. doi: 10.1016/S0040-4039(00)73382-X.
  • Taylor, S. A., D. J. Giroux, K. A. Jaeckle, T. J. Panella, S. R. Dakhil, and S. C. Schold. 1998. Phase II study of didemnin B in central nervous system tumors: A southwest oncology group study. Investigational New Drugs 16 (4):331–2. doi: 10.1023/A:1006273214056.
  • Teixidó, C., E. Arguelaguet, B. Pons, M. Aracil, J. Jimeno, R. Somoza, R. Marés, S. Ramón y Cajal, and J. Hernández-Losa. 2012. ErbB3 expression predicts sensitivity to elisidepsin treatment: In vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines. International Journal of Oncology 41 (1):317–24. doi: 10.3892/ijo.2012.1425.
  • Teixido, C., Mares, R. Aracil, M. Cajal, y S. R. Hernandez-Losa. and J. 2013. Epithelial-mesenchymal transition markers and HER3 expression are predictors of elisidepsin treatment response in breast and pancreatic cancer cell lines. PLoS One 8 (1):e53645. doi: 10.1371/journal.pone.0053645.
  • Teruya, T., H. Sasaki, H. Fukazawa, and K. Suenaga. 2009. Bisebromoamide, a potent cytotoxic peptide from the marine cyanobacterium Lyngbya sp.: isolation, stereostructure, and biological activity. Organic Letters 11 (21):5062–5. doi: 10.1021/ol9020546.
  • Tincu, J. A., and S. W. Taylor. 2004. Antimicrobial peptides from marine invertebrates. Antimicrobial Agents and Chemotherapy 48 (10):3645–54. doi: 10.1128/AAC.48.10.3645-3654.2004.
  • Tinto, W. F., A. J. Lough, S. McLean, W. F. Reynolds, M. Yu, and W. R. Chan. 1998. Geodiamolides H and I, further cyclodepsipeptides from the marine sponge Geodia sp. Tetrahedron 54 (18):4451–8. doi: 10.1016/S0040-4020(98)00157-4.
  • Toske, S. G., and W. Fenical. 1995. Cyclodidemnamide: A new cyclic heptapeptide from the marine ascidian Didemnum molle. Tetrahedron Letters 36 (46):8355–8. doi: 10.1016/0040-4039(95)01806-S.
  • Tran, T. D., N. B. Pham, G. A. Fechner, J. N. Hooper, and R. J. Quinn. 2014. Potent cytotoxic peptides from the Australian marine sponge Pipestela candelabra. Marine Drugs 12:3399–415. doi: 10.3390/md12063399.
  • Tran, T. D., N. B. Pham, G. Fechner, D. Zencak, H. T. Vu, J. N. Hooper, and R. J. Quinn. 2012. Cytotoxic cyclic depsipeptides from the Australian marine sponge Neamphius huxleyi. Journal of Natural Products 75:2200–8. doi: 10.1021/np3006474.
  • Ucak, I., M. Afreen, D. Montesano, C. Carrillo, I. Tomasevic, J. Simal-Gandara, and F. J. Barba. 2021. Functional and bioactive properties of peptides derived from marine side streams. Marine Drugs 19 (2):71. doi: 10.3390/md19020071.
  • Uzair, B., S. Tabassum, M. Rasheed, and S. F. Rehman. 2012. Exploring marine cyanobacteria for lead compounds of pharmaceutical importance. The Scientific World Journal 2012:1–10. doi: 10.1100/2012/179782.
  • Vasko, R. C., R. A. Rodriguez, C. N. Cunningham, V. C. Ardi, D. A. Agard, and S. R. McAlpine. 2010. Mechanistic studies of Sansalvamide A-amide: An allosteric modulator of Hsp90. ACS Medicinal Chemistry Letters 1:4–8. doi: 10.1021/ml900003t.
  • Vera, M. D., and M. M. Joullié. 2002. Natural products as probes of cell biology: 20 years of didemnin research. Medicinal Research Reviews 22:102–45. doi: 10.1002/med.10003.
  • Vervoort, H., W. Fenical, and R. d. A. Epifanio. 2000. Tamandarins A and B: New cytotoxic depsipeptides from a Brazilian ascidian of the family Didemnidae. The Journal of Organic Chemistry 65:782–92. doi: 10.1021/jo991425a.
  • Vijaykrishnaraj, M., and P. Prabhasankar. 2015. Marine protein hydrolysates: Their present and future perspectives in food chemistry–a review. RSC Advances 5 (44):34864–77. doi: 10.1039/C4RA17205A.
  • Wang, J., J. Hu, J. Cui, X. Bai, Y. Du, Y. Miyaguchi, and B. Lin. 2008. Purification and identification of a ACE inhibitory peptide from oyster proteins hydrolysate and the antihypertensive effect of hydrolysate in spontaneously hypertensive rats. Food Chemistry 111 (2):302–8. doi: 10.1016/j.foodchem.2008.03.059.
  • Wang, X., H. Yu, R. Xing, and P. Li. 2017. Characterization, preparation, and purification of marine bioactive peptides. BioMed Research International 2017:9746720. doi: 10.1155/2017/9746720.
  • Wang, X., Z. Zhang, S. Zhang, F. Yang, M. Yang, J. Zhou, Z. Hu, X. Xu, G. Mao, G. Chen, et al. 2021. Antiaging compounds from marine organisms. Food Research International 143:110313. doi: 10.1016/j.foodres.2021.110313.
  • Wang, L., Y. Zou, and B. Jiang. 2015. Process and kinetic models of hydrochloric acid-extracted collagen from Bighead Carp Scale. 5th International Conference on Information Engineering for Mechanics and Materials, pp. 476–482. doi: 10.2991/icimm-15.2015.90.
  • Wergedahl, H., B. Liaset, O. A. Gudbrandsen, E. Lied, M. Espe, Z. Muna, S. Mørk, and R. K. Berge. 2004. Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. The Journal of Nutrition 134 (6):1320–7. doi: 10.1093/jn/134.6.1320.
  • Wesson, K. J., and M. T. Hamann. 1996. Keenamide A, a bioactive cyclic peptide from the marine mollusk Pleurobranchus forskalii. Journal of Natural Products 59 (6):629–31. doi: 10.1021/np960153t.
  • Wijesekara, I., Z.-J. Qian, B. Ryu, D.-H. Ngo, and S.-K. Kim. 2011. Purification and identification of antihypertensive peptides from seaweed pipefish (Syngnathus schlegeli) muscle protein hydrolysate. Food Research International 44 (3):703–7. doi: 10.1016/j.foodres.2010.12.022.
  • Williams, P. G., W. Y. Yoshida, R. E. Moore, and V. J. Paul. 2002. Isolation and structure determination of obyanamide, a novel cytotoxic cyclic depsipeptide from the marine cyanobacterium Lyngbya confervoides. Journal of Natural Products 65 (1):29–31. doi: 10.1021/np0102253.
  • Wipf, P., P. C. Fritch, S. J. Geib, and A. M. Sefler. 1998. Conformational studies and structure − activity analysis of lissoclinamide 7 and related cyclopeptide alkaloids. Journal of the American Chemical Society 120 (17):4105–12. doi: 10.1021/ja973580h.
  • Wipf, P., C. P. Miller, S. Venkatraman, and P. C. Fritch. 1995. Thiolysis of oxazolines: A new, selective method for the direct conversion of peptide oxazolines into thiazolines. Tetrahedron Letters 36 (36):6395–8. doi: 10.1016/0040-4039(95)01322-9.
  • Wrasidlo, W., A. Mielgo, V. A. Torres, S. Barbero, K. Stoletov, T. L. Suyama, R. L. Klemke, W. H. Gerwick, D. A. Carson, and D. G. Stupack. 2008. The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8. Proceedings of the National Academy of Sciences of the United States of America 105 (7):2313–8. doi: 10.1073/pnas.0712198105.
  • Wu, H.-C., H.-M. Chen, and C.-Y. Shiau. 2003. Free amino acids and peptides as related to antioxidant properties in protein hydrolysates of mackerel (Scomber austriasicus). Food Research International 36 (9–10):949–57. doi: 10.1016/S0963-9969(03)00104-2.
  • Wu, Q.-X., M. S. Crews, M. Draskovic, J. Sohn, T. A. Johnson, K. Tenney, F. A. Valeriote, X.-J. Yao, L. F. Bjeldanes, and P. Crews. 2010. Azonazine, a novel dipeptide from a Hawaiian marine sediment-derived fungus, Aspergillus insulicola. Organic Letters 12 (20):4458–61. doi: 10.1021/ol101396n.
  • Wu, H., H.-L. He, X.-L. Chen, C.-Y. Sun, Y.-Z. Zhang, and B.-C. Zhou. 2008. Purification and identification of novel angiotensin-I-converting enzyme inhibitory peptides from shark meat hydrolysate. Process Biochemistry 43 (4):457–61. doi: 10.1016/j.procbio.2008.01.018.
  • Yadav, J., K. Purnima, B. S. Reddy, K. Nagaiah, and A. Ghamdi. 2011. Total synthesis of cryptophycin-24 (arenastatin A) via Prins cyclization. Tetrahedron Letters 52 (50):6709–12. doi: 10.1016/j.tetlet.2011.09.134.
  • Yang, L., R.-x. Tan, Q. Wang, W.-y. Huang, and Y.-x. Yin. 2002. Antifungal cyclopeptides from Halobacillus litoralis YS3106 of marine origin. Tetrahedron Letters 43 (37):6545–8. doi: 10.1016/S0040-4039(02)01458-2.
  • Younes, A., U. Yasothan, and P. Kirkpatrick. 2012. Brentuximab vedotin. Nature Reviews. Drug Discovery 11 (1):19–20. doi: 10.1038/nrd3629.
  • Yu, Z., G. Lang, I. Kajahn, R. Schmaljohann, and J. F. Imhoff. 2008. Scopularides A and B, cyclodepsipeptides from a marine sponge-derived fungus, Scopulariopsis brevicaulis. Journal of Natural Products 71 (6):1052–4. doi: 10.1021/np070580e.
  • Zampella, A., M. V. D'Auria, L. G. Paloma, A. Casapullo, L. Minale, C. Debitus, and Y. Henin. 1996. Callipeltin A, an anti-HIV cyclic depsipeptide from the New Caledonian Lithistida sponge Callipelta sp. Journal of the American Chemical Society 118 (26):6202–9. doi: 10.1021/ja954287p.
  • Zampella, A., V. Sepe, P. Luciano, F. Bellotta, M. C. Monti, M. V. D’Auria, T. Jepsen, S. Petek, M.-T. Adeline, O. LaprévôTe, et al. 2008. Homophymine A, an anti-HIV cyclodepsipeptide from the sponge Homophymia sp. The Journal of Organic Chemistry 73 (14):5319–27. doi: 10.1021/jo800583b.
  • Zeng, M., W. Cui, Y. Zhao, Z. Liu, S. Dong, and Y. Guo. 2008. Antiviral active peptide from oyster. Chinese Journal of Oceanology and Limnology 26 (3):307–12. doi: 10.1007/s00343-008-0307-x.
  • Zhan, K.-X., W.-H. Jiao, F. Yang, J. Li, S.-P. Wang, Y.-S. Li, B.-N. Han, and H.-W. Lin. 2014. Reniochalistatins A-E, cyclic peptides from the marine sponge Reniochalina stalagmitis. Journal of Natural Products 77 (12):2678–84. doi: 10.1021/np5006778.
  • Zhang, H.-J., Y.-H. Yi, G.-J. Yang, M.-Y. Hu, G.-D. Cao, F. Yang, and H.-W. Lin. 2010. Proline-containing cyclopeptides from the marine sponge Phakellia fusca. Journal of Natural Products 73 (4):650–5. doi: 10.1021/np9008267.
  • Zhao, Y., B. Li, S. Dong, Z. Liu, X. Zhao, J. Wang, and M. Zeng. 2009. A novel ACE inhibitory peptide isolated from Acaudina molpadioidea hydrolysate. Peptides 30 (6):1028–33. doi: 10.1016/j.peptides.2009.03.002.
  • Zhao, Y., B. Li, Z. Liu, S. Dong, X. Zhao, and M. Zeng. 2007. Antihypertensive effect and purification of an ACE inhibitory peptide from sea cucumber gelatin hydrolysate. Process Biochemistry 42 (12):1586–91. doi: 10.1016/j.procbio.2007.08.011.
  • Zheng, L.-H., Y.-J. Wang, J. Sheng, F. Wang, Y. Zheng, X.-K. Lin, and M. Sun. 2011. Antitumor peptides from marine organisms. Marine Drugs 9 (10):1840–59. doi: 10.3390/md9101840.
  • Zhou, X., C. Wang, and A. Jiang. 2012. Antioxidant peptides isolated from sea cucumber Stichopus Japonicus. European Food Research and Technology 234 (3):441–7. doi: 10.1007/s00217-011-1610-x.
  • Ziółkowska, N. E., and A. Wlodawer. 2006. Structural studies of algal lectins with anti-HIV activity. Acta Biochimica Polonica 53 (4):617–26. doi: 10.18388/abp.2006_3290.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.